Condition
Crohn's disease news across medications, symptoms, tests, procedures, complications, research, access, and daily life.
Page 2 of 18 · 826 articles
This study links an HLA gene (DRB1) to shared T cell receptor patterns in both Crohn’s disease and ulcerative colitis, suggesting common immune targets across IBD subtypes. That could help researchers identify antigens...
Cure8 could only read part of this source from tradingview.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Investigational or...
Cure8 found this source from stcatharinesstandard.ca, but the page could not be read reliably yet. It is tagged for Crohn's disease and Community and awareness. Open the original article for the full details.
The atlas maps which genes and cell types are different in Crohn's disease, offering clues about why inflammation persists and pointing to specific immune pathways (like JAK/STAT) that are already drug targets. The...
Cure8 found this source from nbc4i.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Ulcerative colitis, and Inflammatory bowel disease. Open the original article for the full details.
Pregnancy planning affects disease and pregnancy outcomes in Crohn’s. Staying in remission and maintaining needed IBD medications during pregnancy reduces risks to both mother and baby, while stopping certain drugs...
This study maps gene activity in over a million gut cells and finds lasting molecular changes in stem cells after inflammation, which could help explain recurrence and guide future research toward new drug targets.
People with Crohn's disease often develop intestinal fibrosis and strictures that current drugs don't reverse; a growing drug pipeline aiming at anti‑fibrotic therapies could change future treatment options.
Based on the title and source metadata, this appears to be a clinical study related to Crohn's disease, Inflammatory bowel disease, and Infliximab. The original article is from gastroendonews.com.
A new Phase 2 Crohn’s trial is planned for Q3 2026 of an investigational DR3‑blocking antibody (SL‑325), which could become a novel treatment approach if later trials show benefit. The report is an investor roundup, so...
Cure8 could only read part of this source from aol.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Ulcerative colitis, and Inflammatory bowel disease.
Cure8 found this source from nbc4i.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Ulcerative colitis, and Inflammatory bowel disease. Open the original article for the full details.
Based on the title and source metadata, this appears to be an event or fundraiser related to Crohn's disease, Inflammatory bowel disease, and Community and awareness. The original article is from wzzm13.com.
Cure8 found this source from youtube.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Colonoscopy. Open the original article for the full details.
Cure8 found this source from youtube.com, but the page could not be read reliably yet. It is tagged for Inflammatory bowel disease, Crohn's disease, and Ulcerative colitis. Open the original article for the full details.
Based on the title and source metadata, this appears to be an event or fundraiser related to Crohn's disease, Ulcerative colitis, and Community and awareness. The original article is from msn.com.
A new national approval means guselkumab (TREMFYA) may soon be an available treatment option for people with Crohn’s disease or ulcerative colitis in Egypt, potentially expanding choices for moderate-to-severe disease....
Cure8 found this source from nbc4i.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Ulcerative colitis, and Community and awareness. Open the original article for the full details.
This study suggests that regional differences in how often and how early advanced drugs are used didn’t change 10-year rates of surgery, hospitalization, or progression to complicated Crohn’s disease in this cohort.
Based on the title and source metadata, this appears to be a basic science related to Crohn's disease, Ulcerative colitis, and Inflammatory bowel disease. The original article is from uk.style.yahoo.com.
Based on the title and source metadata, this appears to be a patient education related to Crohn's disease, Inflammatory bowel disease, and Flare. The original article is from medicalnewstoday.com.
This trial shows darvadstrocel did not outperform placebo for complex perianal Crohn’s fistulas, so it does not support changing care now. High healing rates after surgical curettage and closure suggest the surgical step...
People with Crohn’s and other IBDs have higher rates of depression and suicidal thoughts; recognizing risk factors and warning signs can help you seek timely support. The article gives practical steps you can take with...
The article outlines complications that can come from Crohn’s disease, many of which may need tests, medication, or surgery. Knowing these helps you recognize warning signs and talk with your care team about prevention...
The FDA’s acceptance of Takeda’s sBLA is a regulatory step toward possibly approving IV vedolizumab for children with moderate‑to‑severe UC or Crohn’s. If approved, this would expand an existing adult IBD treatment to...
Cure8 could only read part of this source from contemporarypediatrics.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Ulcerative colitis, Crohn's disease, and Inflammatory bowel...
Long-term (five-year) data suggest guselkumab may provide sustained clinical and endoscopic benefit for people with moderate-to-severe Crohn’s disease, which is important for disease control and reducing need for...
Cure8 found this source from caledonianrecord.com, but the page could not be read reliably yet. It is tagged for Ulcerative colitis, Crohn's disease, and Vedolizumab. Open the original article for the full details.
This could expand an approved, gut-targeted biologic (vedolizumab/ENTYVIO) to children as young as 2 with UC or Crohn’s disease, addressing a pediatric treatment gap if the FDA approves the sBLA. Families and clinicians...
Fibrosis and strictures (fibrostenotic disease) are important unmet problems in Crohn’s disease with limited medical options. An investigational drug that targets PDE4 locally could potentially offer a new approach if...
Fibrostenotic Crohn’s disease (intestinal strictures from scar tissue) has few non-surgical treatment options. An investigational drug aimed at fibrosis could eventually offer a medical alternative to surgery if research...
Firsthand stories can help people with Crohn’s feel less alone and learn about real-life experiences with flares, feeding tubes, medication changes, and advocacy. The piece highlights community support and resources like...
Based on the title and source metadata, this appears to be a conference abstract related to Crohn's disease, Inflammatory bowel disease, and Stricture. The original article is from quiverquant.com.
This describes an investigational drug approach (PALI-2108) aimed at intestinal fibrosis, a key issue in fibrostenotic Crohn’s disease for which there are no approved antifibrotic therapies. Patients and clinicians may...
Based on the title and source metadata, this appears to be a patient education related to Crohn's disease, Inflammatory bowel disease, and Diet and lifestyle. The original article is from msn.com.
Long-term data help patients and clinicians understand whether a biologic maintains benefit and safety over years. Sustained clinical remission and endoscopic healing are important outcomes linked to better long-term...
This study suggests surgery can help heal severe, noncontiguous (metastatic) skin manifestations of Crohn’s disease when medical therapy alone isn’t enough. It highlights that realistic healing may take many months and...
Cure8 found this source from youtube.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Community and awareness. Open the original article for the full...
Routine care and sensible lifestyle choices can reduce flares and complications in Crohn's disease. Missing specialist care, stopping meds, smoking, poor diet, or skipping appointments are common, avoidable risks.
Many people with Crohn’s try cannabis or CBD to ease symptoms. This article explains current evidence is limited: some symptom relief is possible, but there’s no clear proof it reduces gut inflammation and it may risk...
Cure8 found this source from scholarworks.indianapolis.iu.edu, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Ustekinumab. Open the original article for the...
Based on the title and source metadata, this appears to be a case report related to Crohn's disease, Inflammatory bowel disease, and Procedures and surgery. The original article is from cureus.com.
Cure8 indexed this Crohn's and IBD-related source from syneoshealth.com. It is tagged for Ulcerative colitis, Crohn's disease, and Community and awareness. Open the original article for the full details.
Based on the title and source metadata, this appears to be a guideline related to Crohn's disease, Inflammatory bowel disease, and Intestinal ultrasound. The original article is from springermedicine.com.
Fundraisers like the Gutsy Walk raise money for Crohn’s and colitis research, patient support, and community services. They also help reduce isolation by connecting local people affected by IBD.
Local walks raise money for research and support services and help reduce stigma by increasing public awareness of Crohn’s disease and ulcerative colitis. Events like this can connect people living with IBD to local...
Cure8 could only read part of this source from thehindu.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Inflammatory bowel disease, Crohn's disease, and Ulcerative colitis.
Racial and socioeconomic factors can delay Crohn’s diagnosis and limit access to specialist care, testing, and medications — which can lead to worse outcomes. Knowing these disparities can help patients, caregivers, and...
